Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will ...

PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference ...

PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its ...

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...

Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Tuesday, April 22 based on AAII’s Stock Grades.

Embecta Corp. has a twelve month low of $10.00 and a twelve month high of $21.48. The firm has a market capitalization of $659.24 million, a P/E ratio of 11.34, a P/E/G ratio of 0.78 and a beta of ...

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

In the year before Sept. 30, 2024, he eliminated two positions out of 38 holdings (antipollution industrial firm Veralto and medical technology firm Embecta) and added one new one (UnitedHealth).

At close: 4:00:02 pm GMT-4 ...